These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 33328636

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function.
    Lumsden EW, Troppoli TA, Myers SJ, Zanos P, Aracava Y, Kehr J, Lovett J, Kim S, Wang FH, Schmidt S, Jenne CE, Yuan P, Morris PJ, Thomas CJ, Zarate CA, Moaddel R, Traynelis SF, Pereira EFR, Thompson SM, Albuquerque EX, Gould TD.
    Proc Natl Acad Sci U S A; 2019 Mar 12; 116(11):5160-5169. PubMed ID: 30796190
    [Abstract] [Full Text] [Related]

  • 4. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders.
    Lewis V, Rodrigue B, Arsenault E, Zhang M, Taghavi-Abkuh FF, Silva WCC, Myers M, Matta-Camacho E, Aguilar-Valles A.
    J Neurochem; 2023 Jul 12; 166(1):10-23. PubMed ID: 35680556
    [Abstract] [Full Text] [Related]

  • 5. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
    Yao N, Skiteva O, Zhang X, Svenningsson P, Chergui K.
    Mol Psychiatry; 2018 Oct 12; 23(10):2066-2077. PubMed ID: 29158578
    [Abstract] [Full Text] [Related]

  • 6. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray.
    Chou D, Peng HY, Lin TB, Lai CY, Hsieh MC, Wen YC, Lee AS, Wang HH, Yang PS, Chen GD, Ho YC.
    Neuropharmacology; 2018 Sep 01; 139():1-12. PubMed ID: 29953886
    [Abstract] [Full Text] [Related]

  • 7. Selective regulation of GluA subunit synthesis and AMPA receptor-mediated synaptic function and plasticity by the translation repressor 4E-BP2 in hippocampal pyramidal cells.
    Ran I, Gkogkas CG, Vasuta C, Tartas M, Khoutorsky A, Laplante I, Parsyan A, Nevarko T, Sonenberg N, Lacaille JC.
    J Neurosci; 2013 Jan 30; 33(5):1872-86. PubMed ID: 23365227
    [Abstract] [Full Text] [Related]

  • 8. cAMP-dependent protein kinase signaling is required for (2R,6R)-hydroxynorketamine to potentiate hippocampal glutamatergic transmission.
    Riggs LM, Pereira EFR, Thompson SM, Gould TD.
    J Neurophysiol; 2024 Jan 01; 131(1):64-74. PubMed ID: 38050689
    [Abstract] [Full Text] [Related]

  • 9. (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism.
    Riggs LM, Aracava Y, Zanos P, Fischell J, Albuquerque EX, Pereira EFR, Thompson SM, Gould TD.
    Neuropsychopharmacology; 2020 Jan 01; 45(2):426-436. PubMed ID: 31216563
    [Abstract] [Full Text] [Related]

  • 10. (2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions.
    Zanos P, Highland JN, Stewart BW, Georgiou P, Jenne CE, Lovett J, Morris PJ, Thomas CJ, Moaddel R, Zarate CA, Gould TD.
    Proc Natl Acad Sci U S A; 2019 Mar 26; 116(13):6441-6450. PubMed ID: 30867285
    [Abstract] [Full Text] [Related]

  • 11. (R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses.
    Zanos P, Highland JN, Liu X, Troppoli TA, Georgiou P, Lovett J, Morris PJ, Stewart BW, Thomas CJ, Thompson SM, Moaddel R, Gould TD.
    Br J Pharmacol; 2019 Jul 26; 176(14):2573-2592. PubMed ID: 30941749
    [Abstract] [Full Text] [Related]

  • 12. Translational repression of Ccl5 and Cxcl10 by 4E-BP1 and 4E-BP2 restrains the ability of mouse macrophages to induce migration of activated T cells.
    William M, Leroux LP, Chaparro V, Graber TE, Alain T, Jaramillo M.
    Eur J Immunol; 2019 Aug 26; 49(8):1200-1212. PubMed ID: 31032899
    [Abstract] [Full Text] [Related]

  • 13. 4E-BP2-dependent translation in parvalbumin neurons controls epileptic seizure threshold.
    Sharma V, Sood R, Lou D, Hung TY, Lévesque M, Han Y, Levett JY, Wang P, Murthy S, Tansley S, Wang S, Siddiqui N, Tahmasebi S, Rosenblum K, Avoli M, Lacaille JC, Sonenberg N, Khoutorsky A.
    Proc Natl Acad Sci U S A; 2021 Apr 13; 118(15):. PubMed ID: 33876772
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of ketamine action as an antidepressant.
    Zanos P, Gould TD.
    Mol Psychiatry; 2018 Apr 13; 23(4):801-811. PubMed ID: 29532791
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.
    Shaffer CL, Dutra JK, Tseng WC, Weber ML, Bogart LJ, Hales K, Pang J, Volfson D, Am Ende CW, Green ME, Buhl DL.
    Neuropharmacology; 2019 Jul 15; 153():73-81. PubMed ID: 31015046
    [Abstract] [Full Text] [Related]

  • 16. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
    Yokoyama R, Higuchi M, Tanabe W, Tsukada S, Naito M, Yamaguchi T, Chen L, Kasai A, Seiriki K, Nakazawa T, Nakagawa S, Hashimoto K, Hashimoto H, Ago Y.
    Pharmacol Biochem Behav; 2020 Apr 15; 191():172876. PubMed ID: 32088360
    [Abstract] [Full Text] [Related]

  • 17. Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions.
    Ye L, Xiao X, Xu Y, Zheng C, Chen S, Luo T, Li Z, Du Y, Yuan Y, Li L, Liu B, Qin W, Chou D.
    Neuropharmacology; 2022 May 01; 208():108984. PubMed ID: 35131296
    [Abstract] [Full Text] [Related]

  • 18. A Pharmacological Evaluation of the Analgesic Effect and Hippocampal Protein Modulation of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine in Murine Pain Models.
    Das V, Basovich MB, Thomas CJ, Kroin JS, Buvanendran A, McCarthy RJ.
    Anesth Analg; 2024 May 01; 138(5):1094-1106. PubMed ID: 37319016
    [Abstract] [Full Text] [Related]

  • 19. Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression.
    Aleksandrova LR, Wang YT, Phillips AG.
    Mol Brain; 2020 Jun 16; 13(1):92. PubMed ID: 32546197
    [Abstract] [Full Text] [Related]

  • 20. BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model.
    Ju L, Yang J, Zhu T, Liu P, Yang J.
    BMC Psychiatry; 2022 Mar 15; 22(1):182. PubMed ID: 35291971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.